Follitropin biosimilar (BioGeneric Pharma)

促卵泡激素α生物类似药 (BioGeneric Pharma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFollitropin biosimilar (BioGeneric Pharma)
Drug Alias Name促卵泡激素α生物仿制药 (BioGeneric Pharma)FSH follow-on biologic
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionFollicle-stimulating hormone receptor agonists
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility, Female
Global Approved IndicationsInfertility, Female
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEgypt
Original Approved Date2013/05/01
Country/TerritoryEgypt
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiogeneric Pharma
China Registration ClassN/A

Develop Information

Active CompaniesBiogeneric Pharma
Inactive CompaniesN/A
Active IndicationsInfertility, Female
Inactive IndicationsN/A

Other Information

ATC CodeG03GA05
Related LinksN/A